Hiva Azizi

发表

A novel DNA platform designed for vaccine use with high transgene expression and immunogenicity.

H. Fausther-Bovendo, G. Kobinger, T. Racine, 2021, Vaccine.

In Vivo Tethering System to Isolate RNA-Binding Proteins Regulating mRNA Decay in Leishmania.

B. Papadopoulou, Hiva Azizi, 2020, Methods in molecular biology.

Development of Novel Prime-Boost Strategies Based on a Tri-Gene Fusion Recombinant L. tarentolae Vaccine against Experimental Murine Visceral Leishmaniasis

M. Vasei, A. Bolhassani, F. Zahedifard, 2013, PLoS neglected tropical diseases.

Evaluation of novel HIV vaccine candidates using recombinant vesicular stomatitis virus vector produced in serum-free Vero cell cultures.

A. Kamen, A. Garnier, Nasha Nassoury, 2020, Vaccine.

Development and characterization of influenza M2 ectodomain and/or hemagglutinin stalk-based dendritic cell-targeting vaccines

G. Kobinger, Xiaojian Yao, K. Coombs, 2022, Frontiers in Microbiology.

Production of rVSV-ZEBOV in serum-free suspension culture of HEK 293SF cells.

A. Kamen, Sven Ansorge, P. Chahal, 2019, Vaccine.

Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis.

F. Zahedifard, S. Rafati, K. Azadmanesh, 2009, Vaccine.

Did the GJB2 35delG mutation originate in Iran?

K. Kahrizi, H. Najmabadi, C. Nishimura, 2011, American journal of medical genetics. Part A.

Mechanistic insights of SIDER2 retroposon-mediated mRNA decay in Leishmania

H. Azizi, Hiva Azizi, 2017 .

The Pumilio-domain protein PUF6 contributes to SIDER2 retroposon-mediated mRNA decay in Leishmania

C. Dumas, B. Papadopoulou, Hiva Azizi, 2017, RNA.

Cysteine proteinase type III is protective against Leishmania infantum infection in BALB/c mice and highly antigenic in visceral leishmaniasis individuals.

F. Zahedifard, S. Rafati, Y. Taslimi, 2008, Vaccine.

RNA secondary structure and nucleotide composition of the conserved hallmark sequence of Leishmania SIDER2 retroposons are essential for endonucleolytic cleavage and mRNA degradation

Michaela Müller-McNicoll, B. Papadopoulou, T. P. Romão, 2017, PloS one.

A novel intradermal tattoo-based injection device enhances the immunogenicity of plasmid DNA vaccines

G. Kobinger, A. Gomez, R. Kozak, 2022, NPJ vaccines.

Development and characterization of influenza M2 ectodomain and/or HA stalk-based DC-targeting vaccines for different influenza infections

G. Kobinger, Xiaojian Yao, K. Coombs, 2021, bioRxiv.

Optimal Expression, Function, and Immunogenicity of an HIV-1 Vaccine Derived from the Approved Ebola Vaccine, rVSV-ZEBOV

E. Arts, J. Dikeakos, Jamie F S Mann, 2023, Vaccines.

Development and Evaluation of an Ebola Virus Glycoprotein Mucin-Like Domain Replacement System as a New Dendritic Cell-Targeting Vaccine Approach against HIV-1

G. Kobinger, Xiaojian Yao, Zhujun Ao, 2021, Journal of virology.

Transient Liver Damage and Hemolysis Are Associated With an Inhibition of Ebola Virus Glycoprotein-Specific Antibody Response and Lymphopenia

X. Qiu, G. Wong, H. Fausther-Bovendo, 2021, The Journal of infectious diseases.

SIDER2 retroposon-mediated mRNA decay in Leishmania is coupled to translation.

Michaela Müller-McNicoll, B. Papadopoulou, Hiva Azizi, 2017, International journal for parasitology.

Rhesus macaques show increased resistance to repeated SHIV intrarectal exposure following a heterologous regimen of rVSV vector vaccine expressing HIV antigen

H. Fausther-Bovendo, G. Kobinger, E. Arts, 2023, Emerging microbes & infections.

Searching for virulence factors in the non-pathogenic parasite to humans Leishmania tarentolae

H. Najafabadi, S. Rafati, Y. Taslimi, 2009, Parasitology.

Impact of Recombinant VSV-HIV Prime, DNA-Boost Vaccine Candidates on Immunogenicity and Viremia on SHIV-Infected Rhesus Macaques

H. Fausther-Bovendo, J. Pedersen, K. Fowke, 2024, Vaccines.